Vaccination News Home Page            Scandals            subscribe Vaccination NewsLetter

http://bmj.com/cgi/content/full/326/7397/999

PDF of this article Email this article to a friend Respond to this article Read responses to this article PubMed citation Related articles in PubMed Download to Citation Manager Search Medline for articles by: Dyer, O. Alert me when: New articles cite this article

Collections under which this article appears: Other Public Health Basic sciences Genetics Other respiratory infections

BMJ 2003;326:999 ( 10 May )

News

Two strains of the SARS virus sequenced

Owen Dyer, London

Two teams of researchers have sequenced the genome of two strains of the virus believed to be responsible for severe acute respiratory syndrome (SARS). Their results confirm the suspicion that it is a previously unknown coronavirus. Knowledge of the genome, which has been made publicly available, should help in designing new diagnostic tests and eventually a vaccine.

Both teams report their findings in the current issue of the journal Science, which has made the articles freely available on the internet.

Because of the urgency of the problem, the work was conducted with a degree of openness and cooperation rarely seen in the genomic sequencing community. Both teams have posted the full sequence on the website of the National Center for Biotechnology Information, part of the US National Library of Medicine.

Two different strains of the virus, provisionally called SARS-CoV, have been sequenced. The Tor2 strain was isolated in Toronto, Canada, the city hit hardest in the West by the epidemic (www.sciencemag.org/cgi/rapidpdf/1085953v1.pdf).

One millionth of a gram of purified viral genetic material was delivered last month to the Genome Sciences Centre of British Columbia's Cancer Agency in Vancouver, which has been working around the clock ever since.

The Urbani strain was sequenced by the US Centers for Communicable Diseases in Atlanta, Georgia (www.sciencemag.org/cgi/rapidpdf/1085952v1.pdf). It is a common strain in Asia, named after Carlo Urbani, who was an infectious disease specialist at the World Health Organization's office in the Vietnamese capital, Hanoi. He helped to identify the disease as a coronavirus but later died from it.

The differences between the two strains turn out to be minor. Both comprise about 30000 nucleotides, making the genome of SARS-CoV the largest of any RNA virus. It is possible but unlikely that the differences are a result of sequencing errors.

As more strains are sequenced, the degree of difference between them will provide vital clues to the rate of mutation. Although all other known coronaviruses have been allocated to one of three serotypes, both teams of microbiologists believe the new virus belongs in a fourth category of its own.

The structural differences from other coronaviruses, and the lack of evidence of recombination, suggest that the SARS virus is not a result of other viruses swapping DNA with a previously benign coronavirus that already lived unnoticed in humans.

Rather, the researchers say, the evidence indicates that SARS is genuinely new in humans and until recently inhabited an unknown animal species, probably in Guangdong province, China.

Footnotes

The sequences can be found in the database of the National Center for Biotechnology Information GenBank at www.ncbi.nlm.nih.gov (the sequence accession codes for the two strains are AY274119 (Tor2 strain) and AY278741 (Urbani strain)).

© 2003 BMJ Publishing Group Ltd

Rapid responses:

Read all Rapid responses

Vitamin C and SARS

Harri Hemilä

bmj.com, 16 May 2003 [Full text]

PDF of this article Email this article to a friend Respond to this article Read responses to this article PubMed citation Related articles in PubMed Download to Citation Manager Search Medline for articles by: Dyer, O. Alert me when: New articles cite this article

Collections under which this article appears: Other Public Health Basic sciences Genetics Other respiratory infections

© 2003 BMJ Publishing Group Ltd

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.